MicroSintesis
Charlottetown
About MicroSintesis
MicroSintesis is a new life sciences company focused on creating novel anti-infectives. MicroSintesis has developed a unique technology that uses natural bioactive molecules produced by probiotics to reduce significantly the expression of the virulence genes of multiple pathogenic bacteria. The result is a new way to reduce antibiotic use and create a first line of defense in the fight against antibiotic resistance bacteria.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $16.4M
- Last round: Series Unknown (Jun 2019)
- Website: microsintesis.com
- Phone: +1-844-442-1110
Industries & Categories
Biopharma, Biotechnology, Chemical
Social Profiles
Canonical: https://fsome.com/organization/microsintesis-55742 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.